Tibet Aim Pharm (SZSE:002826) Change In Receivables : ¥0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Tibet Aim Pharm Change In Receivables?

Tibet Aim Pharm's change in receivables for the quarter that ended in Mar. 2024 was ¥0.0 Mil. It means Tibet Aim Pharm's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Tibet Aim Pharm's change in receivables for the fiscal year that ended in Dec. 2022 was ¥6.1 Mil. It means Tibet Aim Pharm's Accounts Receivable declined by ¥6.1 Mil from Dec. 2021 to Dec. 2022 .

Tibet Aim Pharm's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥44.2 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Tibet Aim Pharm's Days Sales Outstanding for the three months ended in Mar. 2024 was 25.13.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Tibet Aim Pharm's liquidation value for the three months ended in Mar. 2024 was ¥279.7 Mil.

Tibet Aim Pharm Change In Receivables Historical Data

The historical data trend for Tibet Aim Pharm's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tibet Aim Pharm Change In Receivables Chart

Tibet Aim Pharm Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Receivables

Get a 7-Day Free Trial

-14.21

-3.22

-44.79

86.19

6.11

Tibet Aim Pharm Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Tibet Aim Pharm Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Tibet Aim Pharm (SZSE:002826) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Tibet Aim Pharm's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	44.183	/	160.426	*	91
=	25.13

2. In Ben Graham's calculation of liquidation value, Tibet Aim Pharm's accounts receivable are only considered to be worth 75% of book value:

Tibet Aim Pharm's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	410.48	-	184.117	+	0.75 * 44.183	+	0.5 * 40.397
=	279.7

Tibet Aim Pharm Change In Receivables Related Terms

Thank you for viewing the detailed overview of Tibet Aim Pharm's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Tibet Aim Pharm (SZSE:002826) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Aim Pharm Inc (SZSE:002826) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

No. 6, Linqionggang Road, Lhasa Economic and Technological Development Zone, Tibet Autonomous Region, Lhasa, CHN, 850000

Website

http://www.emyy.cn

Tibet Aim Pharm Inc is the pharmaceutical company based in China. It is mainly engaged in the research and development, production and sales of chemical drugs and proprietary Chinese medicines for common chronic disease such as diabetes and cardiovascular disease as well as medicines for gynecology and obstetrics. The company's products offering includes miglitol tablets, gualoupi injection, nalmefene hydrochloride injection, carbetocin injection; hongjin xiaojie tablets and aceclofenac enteric-coated tablets. The company also expanded its products in the treatment of antibiotic, antiallergic and digestive system.

Executives

Peng Hui	Director
Pang Guo Qiang	Directors, executives
Li Qian Jin	Securities Affairs Representative
Liu Hang	Supervisors

Tibet Aim Pharm (SZSE:002826) Headlines

No Headlines